会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 13. 发明申请
    • FLUORESCENT PROBES FOR MONITORING VOLTAGE BY PHOTO-INDUCED ELECTRON TRANSFER
    • 用于通过光电导体传输监测电压的荧光探针
    • US20140093907A1
    • 2014-04-03
    • US14118836
    • 2012-05-21
    • Evan Walker MillerRoger Y. Tsien
    • Evan Walker MillerRoger Y. Tsien
    • G01N21/64
    • G01N21/6486C09K11/06C09K2211/1007C09K2211/1011C09K2211/1088G01N33/5008G01N33/542G01N2500/10
    • Compounds and methods for determining transmembrane potential, monitoring changes in transmembrane potential, and/or drug screening are provided. In one aspect, compounds of the invention have a structure according to the formula: E-M-A, wherein A is a fluorophore, selected from xanthenes, eoumarins, cyanines, bimanes, and difluoroboradizaindacenes, charged at physiological pH; M is a molecular wire; and E is a hydrophobic moiety, wherein A and E are capable of being involved in a photo-induced, intramolecular electron transfer that quenches the fluorescence of A in response to a voltage condition. When in use, compounds of the invention are membrane-impermeant and oriented within the cell membrane such that the charged moiety localizes at the outer leaflet of the lipid bilayer and the hydrophobic moiety and molecular wire associate with the hydrophobic portion of the lipid bilayer. The rate of electron transfer, fluorescence intensity, and quenching are altered in response to changes in transmembrane potential.
    • 提供了确定跨膜电位的化合物和方法,监测跨膜电位的变化和/或药物筛选。 在一个方面,本发明的化合物具有下式的结构:其中A是荧光团,选自在生理pH下加入的呫吨,香豆素,花青,双马来酰亚胺和二氟硼烷二恶烷; M是分子线; 并且E是疏水部分,其中A和E能够参与光诱导的分子内电子转移,其响应于电压条件淬灭A的荧光。 当使用时,本发明的化合物是膜不渗透的并且在细胞膜内定向,使得带电部分定位在脂质双层的外部小叶上,并且疏水部分和分子线与脂质双层的疏水部分缔合。 响应于跨膜电位的变化,电子转移速率,荧光强度和淬灭速率发生变化。
    • 14. 发明申请
    • PHOTON REDUCING AGENTS FOR FLUORESCENCE ASSAYS
    • 用于荧光测定的光子还原剂
    • US20110076711A1
    • 2011-03-31
    • US12861791
    • 2010-08-23
    • Tom KNAPPGregor ZlokarnikPaul NegulescuRoger Y. TsienTimothy James Rink
    • Tom KNAPPGregor ZlokarnikPaul NegulescuRoger Y. TsienTimothy James Rink
    • C12Q1/02
    • G01N33/582C12Q1/682G01N33/5005G01N33/542Y10S436/80Y10S436/809Y10T436/13C12Q2563/107C12Q2527/125
    • The present invention provides a method for reducing undesirable light emission from a sample using at least one photon producing agent and at least one photon reducing agent (e.g. dye-based photon reducing agents). The present invention further provides a method for reducing undesirable light emission from a sample (e.g., a biochemical or cellular sample) with at least one photon producing agent and at least one collisional quencher. The present invention also provides a method for reducing undesirable light emission from a sample (e.g., a biochemical or cellular sample) with at least one photon producing agent and at least one quencher, such as an electronic quencher. The present invention also provides a system and method of screening test chemicals in fluorescent assays using photon reducing agents. The present invention also provides compositions, pharmaceutical compositions, and kits for practicing these methods.
    • 本发明提供一种使用至少一种光子产生剂和至少一种光子还原剂(例如基于染料的光子还原剂)来减少来自样品的不希望的光发射的方法。 本发明进一步提供了用至少一种光子产生剂和至少一种碰撞猝灭剂减少来自样品(例如生物化学或细胞样品)的不希望的光发射的方法。 本发明还提供了用至少一种光子产生剂和至少一种猝灭剂(例如电子猝灭剂)减少来自样品(例如,生物化学或细胞样品)的不希望的光发射的方法。 本发明还提供了使用光子还原剂在荧光测定中筛选测试化学品的系统和方法。 本发明还提供了用于实施这些方法的组合物,药物组合物和试剂盒。
    • 19. 发明授权
    • Non-oligomerizing tandem fluorescent proteins
    • 非低聚串联荧光蛋白
    • US06852849B2
    • 2005-02-08
    • US09866538
    • 2001-05-24
    • Roger Y. TsienRobert E. Campbell
    • Roger Y. TsienRobert E. Campbell
    • C07K14/435C12Q1/25G01N33/58G01N33/84C07H21/04C07K14/00C12N15/09
    • G01N33/587C07K14/43595C12Q1/25G01N33/84G01N2500/02
    • Non-oligomerizing fluorescent proteins, which are formed by operatively linking two or more monomers of a fluorescent protein, or which are derived from a fluorescent protein having at least one mutation that reduces or eliminates the ability of the fluorescent protein to oligomerize, are provided. The non-oligomerizing fluorescent proteins can be derived from a naturally occurring green fluorescent protein, a red fluorescent protein, or other fluorescent protein, or a fluorescent protein related thereto. Also provided is a fusion protein, which includes a non-oligomerizing fluorescent protein linked to at least one polypeptide of interest. In addition, a polynucleotide encoding a non-oligomerizing fluorescent protein is provided, as is a recombinant nucleic acid molecule, which includes polynucleotide encoding a non-oligomerizing fluorescent protein operatively linked to at least a second polynucleotide. Vectors and host cells containing such polynucleotides also are provided, as are kits containing one or more non-oligomerizing fluorescent proteins or encoding polynucleotides or constructs derived therefrom. Further provided are methods of making and using the proteins and polynucleotides.
    • 提供了通过可操作地连接两种或更多种荧光蛋白单体或衍生自具有降低或消除荧光蛋白低聚的能力的至少一种突变的荧光蛋白而形成的非低聚荧光蛋白。 非低聚荧光蛋白可以衍生自天然存在的绿色荧光蛋白,红色荧光蛋白或其他荧光蛋白,或与其相关的荧光蛋白。 还提供了融合蛋白,其包括与至少一种目的多肽连接的非低聚荧光蛋白。 此外,提供编码非低聚荧光蛋白的多核苷酸,重组核酸分子也包括编码与至少第二个多核苷酸有效连接的非低聚荧光蛋白的多核苷酸。 还提供了含有这种多核苷酸的载体和宿主细胞,以及含有一种或多种非低聚荧光蛋白或编码多核苷酸或由其衍生的构建体的试剂盒。 进一步提供制备和使用蛋白质和多核苷酸的方法。